Robson Capasso MD
Associate Professor at Stanford University, Global Advisor and Faculty Fellow at the Stanford Byers Center for Biodesign.
Director of Innovation at the Hospital Israelita Albert Einstein. Professor of Entrepreneurship and Innovation. Degrees in Economics, Production Engineering. Master’s degree in Business Administration and PhD in Engineering.
Director for Academic Programs at Stanford Biodesign, responsible for developing academic content and helping Stanford Biodesign strengthen its educational programs. Worked at the Stanford Graduate School of Business. Has an MBA from Duke’s Fuqua School of Business and a BA in Communications from UC Santa Barbara.
Works with early-stage healthcare technology companies from conception through commercialization. Led marketing and medical affairs for Transcend Medical, acquired by Novartis in 2016. Biodesign Innovation Fellow from 2010-2011, and received a BS and MS in engineering from Stanford University.
Clinician Scientist, Inventor, Co-Founder Venture-Backed Consumer Electronics Startup, and Stanford Biodesign Faculty Fellowship Alumnus.
Performs cutting-edge eye surgery and researches novel technologies applied to medicine, especially in machine learning, portable imaging, wearables, digital health, and telemedicine.
Antonio Ermírio de Moraes Neto
Entrepreneur and Alumnus of the Stanford Biodesign Innovation cause. In 2017, won of three prizes regarding innovation projects on detection of visual illnesses and smart sensors for home care using artificial intelligence. Also co-funded
Vox Capital, Brazilian impact investing firm focused on education, health, and financial services sectors.
COO at Siris Medical, leveraging artificial intelligence to improve outcomes for radiation oncology patients. Biodesign Innovation Fellowship alumnus and instructor for medical device innovation courses, including 2017 Hong Kong DreamCatchers Medtech Hackathon at Hong Kong University and 2017 Stanford Health++ seminar Instructor.
Stanford trained physician, who completed his MD, MBA, and MS (Mechanical Engineering) at Stanford and is an alumnus of the Stanford Biodesign Innovation Fellowship. He previously led R&D work on Intersect ENT’s Propel Mini for chronic sinusitis (FDA approved), and has been involved in multiple early stage medical companies in Silicon Valley including Foundry’s FIRE1, Cala Health, and most recently Myovant Sciences.
Chairman of Oyster Point Pharmaceuticals, Inc., Biodesign faculty at Stanford University. Vice President, Neurostimulation for Allergan, plc after serving as CEO of Oculeve, Inc. Received a bachelor’s degree in biomedical engineering from Vanderbilt University, M.S. and Ph.D. degrees in biomedical engineering from Case Western Reserve University, and graduated of the Stanford University Biodesign Fellowship, and Vision Research Fellowship at Stanford.
Carlos Henrique Sartorato Pedrotti
Médico Cardiologista formado pelo HC-FMUSP, possui MBA em Gestão em Saúde pelo Insper-SP e é Médico da Equipe de Telemedicina do Hospital ISraelita Albert Einstein desde 2012. Atualmente é Supervisor do programa de Pronto Atendimento Virtual do HIAE.
Natalia Novaes Pelizari Côrte Leal
Neurologist, Movement Disorders Specialist and PhD Student at University of São Paulo. Researcher of Functional Magnetic Resonance Imaging in Movement Disorders. Preceptor of Neurology Residency of Hospital Israelita Albert Einstein.
Formado em Medicina na Faculdade de Medicina do ABC, especialista em Oftalmologia pelo Conselho Brasileiro de Oftalmologia e possui MBA em Gestão de Serviços de Saúde pela UNIFESP. Com mais de 15 anos de experiência em medicina e health-tech, patenteou dispositivos médicos na área de Oftalmologia, foi Medical Consultant da Intersystems e é um dos fundadores da Livance Consultórios Inteligentes.
Pedro Alves Lemos Neto
Coordenador de cardiologia intervencionista do Hospital Israelita Albert Einstein, professor colaorador da Faculdade de Medicina da Universidade de São Paulo e professor visitante do MIT.